Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
0.3001
-0.0041 (-1.35%)
At close: Jun 6, 2025, 4:00 PM
0.3000
-0.0001 (-0.03%)
After-hours: Jun 6, 2025, 7:16 PM EDT
Co-Diagnostics Revenue
Co-Diagnostics had revenue of $50.28K in the quarter ending March 31, 2025, a decrease of -89.25%. This brings the company's revenue in the last twelve months to $3.50M, down -47.62% year-over-year. In the year 2024, Co-Diagnostics had annual revenue of $3.92M, down -42.53%.
Revenue (ttm)
$3.50M
Revenue Growth
-47.62%
P/S Ratio
2.65
Revenue / Employee
$26,497
Employees
132
Market Cap
10.12M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.92M | -2.90M | -42.53% |
Dec 31, 2023 | 6.81M | -27.41M | -80.09% |
Dec 31, 2022 | 34.22M | -63.67M | -65.04% |
Dec 31, 2021 | 97.89M | 23.33M | 31.30% |
Dec 31, 2020 | 74.55M | 74.34M | 34,579.90% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
CODX News
- 23 days ago - Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference - GlobeNewsWire
- 4 weeks ago - Co-Diagnostics, Inc. (CODX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast - GlobeNewsWire
- 2 months ago - Co-Diagnostics, Inc. (CODX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results - PRNewsWire
- 3 months ago - Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast - PRNewsWire
- 3 months ago - Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025 - PRNewsWire